Sex-stratified outcomes: what the data shows women Women in the 12mg dose groups lost 28.5 percent and 26.6 percent of body weight
4 full doses of 10 mg each (40 mg total), 12 needles 32g 4mm included, instruction manual
The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)
Microneedle patches are experimental : while research exists, none have FDA approval for delivering weight-loss peptides
Pi-Sunyer X, Astrup A, Fujioka K et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Monitoring parameters: Standard GLP-1 monitoring: weight, glycemic parameters, blood pressure, side effects